Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
The current Apellis Pharmaceuticals(APLS) stock price is $41.02, with a market capitalization of 5.25B. The stock trades at a price-to-earnings (P/E) ratio of 41.01.
On 2026-05-10, Apellis Pharmaceuticals(APLS) stock moved within a range of $41.00 to $41.07. With shares now at $41.02, the stock is trading +0.0% above its intraday low and -0.1% below the session's peak.
Trading volume for Apellis Pharmaceuticals(APLS) stock has reached 7.07M, versus its average volume of 3.85M.
Over the past 52 weeks, Apellis Pharmaceuticals(APLS) stock has traded between a high of $41.14 and a low of $16.10.
Over the past 52 weeks, Apellis Pharmaceuticals(APLS) stock has traded between a high of $41.14 and a low of $16.10.
APLS News
Advertisement Event context and recent stock performance Apellis Pharmaceuticals (APLS) has drawn fresh attention after recent trading data showed the stock f...
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Analyst ratings
95%
of 21 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.